• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sequent Scientific Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 2086.0
  • ISIN : INE807F01027
168.61 -3 (-1.95%)
  • As on 03 Aug 2025 (EOD)

  • Today’s Low

    167.13

  • Today’s High

    172.62

  • Open

    171.00

  • Perv Close

    171.97

  • 52W Low

    117.35

  • 52W High

    240.70

Key Indicators

  • P/E(TTM)

    247.57

  • Mar.Cap (₹Cr.)

    4,220.90

  • Div & Yield %

    0.00

  • Book Value(₹)

    45.65

  • Debt-Equity Ratio

    -1.95

  • AGM Date

    01-Aug-2025

  • EPS

    0.68

  • P/E Ratio

    247.57

Financials Ratios

  • Debt-Equity Ratio

    0.69

  • Mar.Cap (₹Cr.)

    4,220.90

  • RONW (%)

    -3.09

  • ROCE (%)

    0.45

Score Board

  • Equity (₹ in Cr.)

    50.07

  • BV (₹)

    45.60

  • Sales( ₹ in Cr.)

    178.26

  • NP (in Cr.)

    17.10

  • NP Var(%)

    640.0

  • Div%

    0.0

  • CPS (₹)

    1.00

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    4,214.39

  • 52 Week High

    240.70

  • 52 Week Low

    117.35

  • Price BSE

    168.0

  • Price NSE

    169.00

  • Market Capital( in Cr.)

    4,214.39

  • P/C Ratio

    163.20

  • P/E Ratio

    246.00

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 178.26 168.52 222.69 219.63 265.46 227.33
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 178.26 168.52 222.69 219.63 265.46 227.33
Other Income 51.32 45.98 28.24 27.64 19.97 14.56
Stock Adjustments -8.31 -5.35 -19.42 19.73 15.56 3.89
Total Income 221.27 209.15 231.51 267.00 300.99 245.78
EXPENDITURE :            
Raw Materials 97.19 102.54 116.50 128.39 124.43 116.93
Power and Fuel Cost 12.53 12.89 13.93 11.96 12.77 12.74
Employee Cost 35.05 30.05 36.66 27.38 22.42 17.10
Other Manufacturing Expenses 14.15 21.26 41.54 52.53 57.73 50.56
Selling and Administration Expenses 18.03 17.86 19.49 19.40 20.27 9.98
Miscellaneous Expenses 9.64 11.49 1.52 0.45 10.68 1.68
Employee Benefit Expenses 35.05 30.05 36.66 27.38 22.42 17.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 186.59 196.09 229.63 240.11 248.29 208.98
Operating Profit 34.67 13.06 1.88 26.89 52.70 36.80
Interest 3.96 4.36 2.51 1.61 2.68 5.04
Gross Profit 30.71 8.70 -0.63 25.28 50.02 31.76
Depreciation 8.67 8.94 9.12 9.59 9.13 8.95
Profit Before Tax 22.04 -0.24 -9.75 15.69 40.89 22.81
Current Tax 3.88 0.46 -0.57 0.37 6.09 3.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.37 -1.32 -3.09 0.52 2.69 -1.71
Reported Net Profit 15.79 0.62 -6.08 14.80 32.11 21.34
Extraordinary Items -1.30 -1.69 0.00 0.00 -0.75 0.00
Adjusted Net Profit 17.09 2.31 -6.08 14.80 32.86 21.34
Adjustment below Net Profit -0.12 2.65 0.09 0.07 43.38 -1.30
P & L Balance brought forward 42.03 38.76 30.56 28.03 -47.47 -62.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 -14.19 12.34 0.00 4.86
P & L Balance carried down 57.70 42.03 38.76 30.56 28.03 -47.47
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 25.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.50 0.00
Earnings Per Share-Unit Curr 0.63 0.02 -0.24 0.60 1.29 0.86
Earnings Per Share(Adj)-Unit Curr 0.63 0.02 -0.24 0.60 1.29 0.86
Book Value 45.65 43.59 42.43 41.55 41.45 35.68
Book Value(Adj)-Unit Curr 45.65 43.59 42.43 41.55 41.45 35.68

Shareholding Pattern

  • Promoter Group

    52.61%

  • Public Share Holding

    47.23%

  • Custodian

    0.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 131,680,103 131,680,103.00 131,680,103 131,680,103
Sub Total 131,680,103 52.61 131,680,103 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15,386,585 6.15 15,386,585 53
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 25,237,647 10.08 25,237,647 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,264,471 2.90 7,264,471 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 47,888,703 19.13 47,888,703 75
2] Non Institution
Bodies Corporate 8,420,093 3.36 8,420,093 810
Clearing Members 9,359 0.00 9,359 6
Directors of their Relatives 0 0.00 0 0
Employees 362,308 0.14 362,308 72
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,306,340 1.32 3,306,340 2,647
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,193,960 0.88 2,193,960 2,022
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,329,858 2.53 6,329,858 26
Individuals holding nominal share capital up to Rs. 1 lakh 49,659,576 19.84 49,634,571 141,659
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 42,445 0.02 42,445 1
Sub Total 70,323,939 28.10 70,298,934 147,243
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 412,250 0.16 412,250 1
Total Shares held by Custodians and against which Depository Receipts have been issued 412,250 0.16 412,250 1
Grand Total ( A + B + C ) 250,304,995 100.00 250,279,990 147,320

Company Background

Sequent Scientific LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sequent Scientific Ltd
  • BSE Code : 2086.0
  • ISIN : INE807F01027

  • Incorporation Year

    1985

  • Registered Office

    301 Dosti Pinnacle 3rd Floor
    Plot E7 Road No 22 Wagle Indl, Thane,
    Maharashtra-400604

  • Telephone

    91-022-41114777

  • FAX

    91-022-41114754

  • Chairman

    Kamal K Sharma

  • Managing Director

    N Rajaram

  • Company Secretary

    PHILLIP TROTT

  • Auditor

    SRBC & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Sequent Scientific Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sequent Scien. 168.35 229.19 178.26 267.22 2.23
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10